Objective Discuss the safety and effectiveness of flow diverter device and traditional stent inthetreatment of unruptured ophthalmic segment aneurysms. Methods A retrospective analysis from January 2017 to January 2023 was performed on the clinical data of 70 cases of unruptured aneurysms in the Department of Neurosurgery of Southern Theater General Hospital treated with stent-assisted embolization. According to the type of implanted stents， theywere divided into flow diverter device group （n = 21） and traditional stent group （n = 49）， and the postoperative clinical effects and complications of the two groups were compared. Results The two groups of patients followed 3 to 24 months， with an average of （14.4 ± 1.82） months. The results of perioperative and follow-up showed that the inclusion rate was higher in the flow diverter device group and the traditional stent group （93.3% vs. 87.9%）， with no significant difference（P > 0.05）， and the incidence of perioperative and short-term complications was lower（0 vs. 6.1%） in the flow diverter device group than in the traditional stent group，and there currencies rate in the flow diverter device group was lower than that in the traditional stent group（0 vs. 6.1%）， but the difference was not significant （P > 0.05）. Conclusion Flow diverter devices and traditional stents in the treatment of unruptured ophthalmic segment aneurysmsare feasible， safe and effective. Preliminary results suggest that the incidence of short-term complications and retreatment is lower after treatment with flow diverter devices， and the operation time is short， but further studies are needed to validate long-term complications in patients.